Efficacy of oral extended-release oxybutynin in cognitively impaired older nursing home residents with urge urinary incontinence: a randomized placebo-controlled trial.
暂无分享,去创建一个
[1] Z. Gabriel,et al. The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. , 2008, European urology.
[2] J. Wyman,et al. Randomized, Placebo‐Controlled Trial of the Cognitive Effect, Safety, and Tolerability of Oral Extended‐Release Oxybutynin in Cognitively Impaired Nursing Home Residents with Urge Urinary Incontinence , 2008, Journal of the American Geriatrics Society.
[3] A. Cerulli,et al. Is drug therapy for urinary incontinence used optimally in long-term care facilities? , 2007, Journal of the American Medical Directors Association.
[4] R. Dmochowski,et al. Transdermal oxybutynin in the treatment of adults with overactive bladder: combined results of two randomized clinical trials , 2005, World Journal of Urology.
[5] J. Wyndaele,et al. Treatment of overactive bladder in the older patient: pooled analysis of three phase III studies of darifenacin, an M3 selective receptor antagonist. , 2005, European urology.
[6] C. Dubeau,et al. Urinary incontinence in the nursing home: practical approach to evaluation and management. , 2004, Clinics in geriatric medicine.
[7] J. Susset,et al. Trospium chloride improves overactive bladder symptoms: a multicenter phase III trial. , 2004, The Journal of urology.
[8] P. Meffan,et al. Randomized, double‐blind placebo‐ and tolterodine‐controlled trial of the once‐daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder , 2004, BJU international.
[9] S. Stanton,et al. Efficacy, Safety, and Tolerability of Extended‐Release Once‐Daily Tolterodine Treatment for Overactive Bladder in Older versus Younger Patients , 2002, Journal of the American Geriatrics Society.
[10] J. Ouslander,et al. Implementation of a nursing home urinary incontinence management program with and without tolterodine. , 2001, Journal of the American Medical Directors Association.
[11] J. Malone-lee,et al. Overactive bladder: special considerations in the geriatric population. , 2000, The American journal of managed care.
[12] P. Goode,et al. Combined Behavioral and Drug Therapy for Urge Incontinence in Older Women , 2000, Journal of the American Geriatrics Society.
[13] P. Goode,et al. Contributions Behavioral vs Drug Treatment for Urge Urinary Incontinence in Older Women A Randomized Controlled Trial , 2000 .
[14] J. Schnelle,et al. Developing Rehabilitative Behavioral Interventions for Long‐Term Care: Technology Transfer, Acceptance, and Maintenance Issues , 1998, Journal of the American Geriatrics Society.
[15] J. Schnelle,et al. Does Oxybutynin Add to the Effectiveness of Prompted Voiding For Urinary Incontinence Among Nursing Home Residents? A Placebo‐Controlled Trial , 1995, Journal of the American Geriatrics Society.
[16] B Bates-Jensen,et al. Predictors of successful prompted voiding among incontinent nursing home residents. , 1995, JAMA.
[17] D. Mehr,et al. MDS Cognitive Performance Scale. , 1994, Journal of gerontology.
[18] J. Schnelle. Managing Urinary Incontinence in the Elderly , 1991 .
[19] J. Schnelle,et al. Statistical quality control in nursing homes: assessment and management of chronic urinary incontinence. , 1990, Health services research.
[20] N. Resnick,et al. The pathophysiology of urinary incontinence among institutionalized elderly persons. , 1989, The New England journal of medicine.
[21] J. Ouslander,et al. Habit Training and Oxybutynin for Incontinence in Nursing Home Patients: A Placebo‐controlled Trial , 1988, Journal of the American Geriatrics Society.
[22] L. Rubenstein,et al. Incontinence Among Nursing Home Patients: Clinical and Functional Correlates , 1987, Journal of the American Geriatrics Society.
[23] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.